Selumetinib shrinks pediatric tumors, results of an early-phase clinical trial

Dr. Brigitte Widemann, leader of MyPART, describes her recent success developing treatment for a rare tumor, plexiform neurofibroma, and how natural history studies at NIH lay the foundation for finding new treatments for rare tumors.